exam June 2013 Shashi Kumar Gupta INDIA supervisor: Prof. Dr. Thum, IFB-Tx, project: MicroRNAs as therapeutic targets in cardiac disease Final exam June 2013 Christine Happle (Dr.med.) GERMANY supervisor:
Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. FEBS Lett 586 , 310-313. PubMed-Link Strotmeier J, Gu S, Jutzi S, Mahrhold
surgery (WSG ADAPT trial). Suppression of tumor cell proliferation in post- relative to matched pre-therapeutic tumor specimens allows to classify patients and tumors as endocrine-responsive or non-responsive [...] determined by the loss of E-cadherin. Secondary genetic alterations, growth characteristics and therapeutic responsiveness are of particular interest. Molecular pathology of microglandular adenosis (MGA)
glucose transporter palmitoylation in human peripheral blood mononuclear cells. Expert opinion on therapeutic targets. 2019;23(10):883-91. DOI Research projekt 4 Effectiveness and mechanisms of action of [...] aims to find out which intervention is most suitable for which patient and which factors cause therapeutic success. E.g., as part of moderator analyzes, this study aims to answer whether early traumatic [...] A follow-up survey after 48 weeks will provide valuable data regarding the sustainability of therapeutic improvements. Finally, the health economic potential of the interventions is examined with the
integration approaches and high-throughput imaging will help us to identify targets for future therapeutic interventions. Publications: Voss, C., Han, L., Ansari, M., Strunz, M., Haefner, V., Ballester-Lopez
Pneumology Project: Dissecting the onset of macrophages from human iPSC for disease modelling and therapeutic applications Juliette Nowak GERMANY Supervisors: from September 2019: Prof. Dr. Axel Schambach/
OE 6830, project: Tetherin and Vpu: Molecular studies and clinical relevance of a new potential therapeutic target in HIV-infection Final exam November 2011 Elena Lam GERMANY supervisor: Prof. Dr. Heim,
disorders and are, therefore, increasingly considered in psychiatric diseases models and experimental therapeutic approaches. Moreover, numerous neuroimmunological diseases like autoimmune encephalitis or multiple
Kraemer A, Knapp S, Windheim M, Kotlyarov A, Menon MB & Gaestel M Cell Death Discov 9: 262 On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer Boudghene-Stambouli F, Soulez M, Ronkina N,
1411971 Grote-Koska D, Czajkowski S, Brand K. ( 2015 ). Performance of the New RapidFire System for Therapeutic Monitoring of Immunosuppressants. Ther. Drug. Monit. 37: 400-404. Grote-Koska D, Czajkowski S,